PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452
DIHI announces 2019 RFA Innovation Awards
Duke Health invests in innovation projects The Duke Institute for Health Innovation (DIHI) has announced that it will support high-potential innovation projects in the areas of population health and analytics, novel patient interactions, new and…
DIHI announces 2019 RFA Innovation Awards
Duke Health invests in innovation projects The Duke Institute for Health Innovation (DIHI) has announced that it will support high-potential innovation projects in the areas of population health and analytics, novel patient interactions, new and…
Menarini Group, Radius Health Announce License Agreement for Elacestrant
– Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development – Elacestrant further strengthens Menarini’s global oncology portfolio, recently bolstered by the acquisition of Stemline…